Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • For Subscribers
    • For Advertisers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in

Search

  • Advanced search
Pharmacological Reviews
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
Pharmacological Reviews

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • For Subscribers
    • For Advertisers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit Pharm Rev on Facebook
  • Follow Pharm Rev on Twitter
  • Follow ASPET on LinkedIn
Review ArticleReview Article

Exchange Protein Directly Activated by cAMP (epac): A Multidomain cAMP Mediator in the Regulation of Diverse Biological Functions

Martina Schmidt, Frank J. Dekker and Harm Maarsingh
Martin C. Michel, ASSOCIATE EDITOR
Pharmacological Reviews April 2013, 65 (2) 670-709; DOI: https://doi.org/10.1124/pr.110.003707
Martina Schmidt
Department of Molecular Pharmacology (M.S., H.M.), Groningen Research Institute for Pharmacy, University of Groningen, The Netherlands; Groningen Research Institute for Asthma and COPD, University of Groningen, University Medical Center Groningen, The Netherlands (M.S., H.M.); and Department of Pharmaceutical Gene Modulation (F.J.D.), Groningen Research Institute for Pharmacy, University of Groningen, The Netherlands (M.S., F.J.D., H.M.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Frank J. Dekker
Department of Molecular Pharmacology (M.S., H.M.), Groningen Research Institute for Pharmacy, University of Groningen, The Netherlands; Groningen Research Institute for Asthma and COPD, University of Groningen, University Medical Center Groningen, The Netherlands (M.S., H.M.); and Department of Pharmaceutical Gene Modulation (F.J.D.), Groningen Research Institute for Pharmacy, University of Groningen, The Netherlands (M.S., F.J.D., H.M.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Harm Maarsingh
Department of Molecular Pharmacology (M.S., H.M.), Groningen Research Institute for Pharmacy, University of Groningen, The Netherlands; Groningen Research Institute for Asthma and COPD, University of Groningen, University Medical Center Groningen, The Netherlands (M.S., H.M.); and Department of Pharmaceutical Gene Modulation (F.J.D.), Groningen Research Institute for Pharmacy, University of Groningen, The Netherlands (M.S., F.J.D., H.M.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martin C. Michel
Department of Molecular Pharmacology (M.S., H.M.), Groningen Research Institute for Pharmacy, University of Groningen, The Netherlands; Groningen Research Institute for Asthma and COPD, University of Groningen, University Medical Center Groningen, The Netherlands (M.S., H.M.); and Department of Pharmaceutical Gene Modulation (F.J.D.), Groningen Research Institute for Pharmacy, University of Groningen, The Netherlands (M.S., F.J.D., H.M.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

This article has a correction. Please see:

  • Correction to “Exchange Protein Directly Activated by cAMP (epac): A Multidomain cAMP Mediator in the Regulation of Diverse Biological Functions” - July 01, 2013

Abstract

Since the discovery nearly 60 years ago, cAMP is envisioned as one of the most universal and versatile second messengers. The tremendous feature of cAMP to tightly control highly diverse physiologic processes, including calcium homeostasis, metabolism, secretion, muscle contraction, cell fate, and gene transcription, is reflected by the award of five Nobel prizes. The discovery of Epac (exchange protein directly activated by cAMP) has ignited a new surge of cAMP-related research and has depicted novel cAMP properties independent of protein kinase A and cyclic nucleotide-gated channels. The multidomain architecture of Epac determines its activity state and allows cell-type specific protein-protein and protein-lipid interactions that control fine-tuning of pivotal biologic responses through the “old” second messenger cAMP. Compartmentalization of cAMP in space and time, maintained by A-kinase anchoring proteins, phosphodiesterases, and β-arrestins, contributes to the Epac signalosome of small GTPases, phospholipases, mitogen- and lipid-activated kinases, and transcription factors. These novel cAMP sensors seem to implement certain unexpected signaling properties of cAMP and thereby to permit delicate adaptations of biologic responses. Agonists and antagonists selective for Epac are developed and will support further studies on the biologic net outcome of the activation of Epac. This will increase our current knowledge on the pathophysiology of devastating diseases, such as diabetes, cognitive impairment, renal and heart failure, (pulmonary) hypertension, asthma, and chronic obstructive pulmonary disease. Further insights into the cAMP dynamics executed by the Epac signalosome will help to optimize the pharmacological treatment of these diseases.

Footnotes

  • This work was supported by grants from the Nederlands Astma Fonds (NAF 3.2.09.034, NAF 3.2.11.015); and a Rosalind Franklin Fellowship from the University of Groningen to M.S.; and a grant from the NWO VIDI program (016.122.302) to F.J.D.; H.M. is supported by Merck Sharp & Dohme (Oss, The Netherlands).

  • dx.doi.org/10.1124/pr.110.003707.

  • Copyright © 2013 by The American Society for Pharmacology and Experimental Therapeutics
View Full Text

Log in using your username and password

Forgot your user name or password?

Pay Per Article - You may access this article (from the computer you are currently using) for 1 day for US$35.00

Regain Access - You can regain access to a recent Pay per Article purchase if your access period has not yet expired.

PreviousNext
Back to top

In this issue

Pharmacological Reviews: 65 (2)
Pharmacological Reviews
Vol. 65, Issue 2
1 Apr 2013
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Pharmacological Reviews article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Exchange Protein Directly Activated by cAMP (epac): A Multidomain cAMP Mediator in the Regulation of Diverse Biological Functions
(Your Name) has forwarded a page to you from Pharmacological Reviews
(Your Name) thought you would be interested in this article in Pharmacological Reviews.
Citation Tools
Review ArticleReview Article

Biology of the Epac Signalosome

Martina Schmidt, Frank J. Dekker and Harm Maarsingh
Pharmacological Reviews April 1, 2013, 65 (2) 670-709; DOI: https://doi.org/10.1124/pr.110.003707

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Review ArticleReview Article

Biology of the Epac Signalosome

Martina Schmidt, Frank J. Dekker and Harm Maarsingh
Pharmacological Reviews April 1, 2013, 65 (2) 670-709; DOI: https://doi.org/10.1124/pr.110.003707
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • I. Introduction
    • II. Biologic Functions of Epac
    • III. Concluding Remarks and Future Directions
    • Acknowledgments
    • Authorship Contributions
    • Footnotes
    • Abbreviations
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Pharmacology of GPCRs in Asthma Therapy and Drug Action
  • Pediatric Cancer Drug Development
  • Targeting Foam Cells by Natural Products
Show more Review Articles

Similar Articles

  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Pharmacological Reviews
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacology Research & Perspectives
ISSN 1521-0081 (Online)

Copyright © 2019 by the American Society for Pharmacology and Experimental Therapeutics